180 related articles for article (PubMed ID: 26405490)
1. [Erysipeloid cutaneous leishmaniasis: about a clinical observation].
El kartouti A; Elbenaye J; Miloudi M
Pan Afr Med J; 2015; 21():54. PubMed ID: 26405490
[TBL] [Abstract][Full Text] [Related]
2. Unusual form of cutaneous leishmaniasis: erysipeloid form.
Mnejja M; Hammami B; Chakroun A; Achour I; Charfeddine I; Chakroun A; Turki H; Ghorbel A
Eur Ann Otorhinolaryngol Head Neck Dis; 2011 Apr; 128(2):95-7. PubMed ID: 21251895
[TBL] [Abstract][Full Text] [Related]
3. [Facial inflammatory cutaneous leishmaniasis or "erysipeloid"].
El Benaye J; Miloudi M; El Haouri M
Ann Dermatol Venereol; 2015 May; 142(5):379-80. PubMed ID: 25813188
[No Abstract] [Full Text] [Related]
4. Cutaneous lupoid leishmaniasis: a case report.
Ferahbaş A; Mistik S; Utaş S; Yaman O; Canoz O; Doganay M; Aşçioglu O
Cutis; 2006 Jan; 77(1):25-8; quiz 37-8. PubMed ID: 16475491
[TBL] [Abstract][Full Text] [Related]
5. Old-world leishmaniasis of the auricle.
Skevas A; Kastanioudakis I; Bai M; Kostoula A
Lancet; 1997 Jan; 349(9044):28-9. PubMed ID: 8988123
[No Abstract] [Full Text] [Related]
6. A strange infiltrative plaque on the face.
Guarneri C; Wollina U; Chokoeva A; Lotti TM; Tchernev G
Braz J Infect Dis; 2016; 20(2):214-5. PubMed ID: 26748228
[No Abstract] [Full Text] [Related]
7. Disseminated cutaneous leishmaniasis: ulcerovegetative and ulcero-crusted lesions.
Sgarbi IM; Santos FD; Monteiro VE; Fonseca SN; Bernardes Filho F
Braz J Infect Dis; 2017; 21(2):201-202. PubMed ID: 28012931
[No Abstract] [Full Text] [Related]
8. A case of erysipeloid cutaneous leishmaniasis: atypical and unusual clinical variant.
Ceyhan AM; Yildirim M; Basak PY; Akkaya VB; Erturan I
Am J Trop Med Hyg; 2008 Mar; 78(3):406-8. PubMed ID: 18337335
[TBL] [Abstract][Full Text] [Related]
9. Use of meglumine antimoniate in canine leishmaniasis.
Lamothe J
Vet Rec; 2004 Mar; 154(12):378. PubMed ID: 15074332
[No Abstract] [Full Text] [Related]
10. Chronic zosteriform cutaneous leishmaniasis.
Omidian M; Mapar MA
Indian J Dermatol Venereol Leprol; 2006; 72(1):41-2. PubMed ID: 16481709
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment of lupoid cutaneous leishmaniasis with glucantime and topical trichloroacetic acid (a case report).
Nilforoushzadeh MA; Sadeghian G; Jaffary F; Ziaei H; Shirani-Bidabad L; Mahzoni P
Korean J Parasitol; 2008 Sep; 46(3):175-7. PubMed ID: 18830058
[TBL] [Abstract][Full Text] [Related]
12. American cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis resistant to meglumine antimoniate, but with good response to pentamidine: a case report.
Pimentel MI; Baptista C; Rubin EF; Vasconcellos Ede C; Lyra MR; Salgueiro Mde M; Saheki MN; Rosalino CM; Madeira Mde F; Silva AF; Confort EM; Schubach Ade O
Rev Soc Bras Med Trop; 2011; 44(2):254-6. PubMed ID: 21552747
[TBL] [Abstract][Full Text] [Related]
13. Comparing the efficiency of topical paromomycin with intralesional meglumine antimoniate for cutaneous leishmaniasis.
Moosavi Z; Nakhli A; Rassaii S
Int J Dermatol; 2005 Dec; 44(12):1064-5. PubMed ID: 16409282
[No Abstract] [Full Text] [Related]
14. Systemic Meglumine Antimoniate in Cutaneous Leishmaniasis of Children: Clinical and Laboratory Complications.
Layegh P; Khademi Z; Afzal Aghaee M; Moghiman T
J Pediatric Infect Dis Soc; 2015 Dec; 4(4):356-8. PubMed ID: 26582874
[TBL] [Abstract][Full Text] [Related]
15. Disseminated cutaneous leishmaniasis: a patient with 749 lesions.
Sousa AQ; Pompeu MM; Sólon FR; Frutuoso MS; Teixeira MJ; Silva TM
Braz J Infect Dis; 2006 Jun; 10(3):230. PubMed ID: 17568857
[No Abstract] [Full Text] [Related]
16. Effective meglumine antimoniate intralesional therapy for Chiclero's ulcer refractory to systemic liposomal amphotericin B.
Spinicci M; Zammarchi L; Gramiccia M; Di Muccio T; Bartolozzi D; Corsi P; Trotta M; Bartoloni A
J Travel Med; 2021 Aug; 28(6):. PubMed ID: 32918547
[No Abstract] [Full Text] [Related]
17. Intralesional injections of meglumine antimoniate to treat complex facial leishmania infantum acquired in Spain: a case report.
Mostmans Y; Van Gysel J; Vanden Nest H; Mervillie K; Richert B; Clevenbergh P
J Eur Acad Dermatol Venereol; 2022 Jul; 36(7):e548-e550. PubMed ID: 35181939
[No Abstract] [Full Text] [Related]
18. Unusual manifestation of genital cutaneous leishmaniasis in an immunocompetent patient from São Paulo, Brazil: A case report.
Reis LC; Lindoso JAL; Celeste BJ; Braz LMA; Ramos-Sanchez EM; Yamashiro-Kanashiro EH; Goto H; Oyafuso LKM
Rev Soc Bras Med Trop; 2021; 54():e0514-2020. PubMed ID: 33759920
[TBL] [Abstract][Full Text] [Related]
19. [N-methyl glucamine antimoniate or Glucantime].
Rapp C; Simon F; Dordain ML
Med Trop (Mars); 2000; 60(4):342-3. PubMed ID: 11436584
[No Abstract] [Full Text] [Related]
20. Leishmaniasis of the lip.
Veraldi S; Rigoni C; Gianotti R
Acta Derm Venereol; 2002; 82(6):469-70. PubMed ID: 12575860
[No Abstract] [Full Text] [Related]
[Next] [New Search]
